cPass

Credit: GenScript Biotech

By Dean Koh 08:11 am May 15, 2020
Singapore’s Duke-NUS Medical School, GenScript Biotech and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) announced an exclusive agreement to co-develop and manufacture a unique serological coronavirus (COVID-19) detection system known as the surrogate virus neutralization test (sVNT) or cPass. This first of its kind test allows rapid...